CLOV vs COLL
Clover Health Investments Corp (CLOV) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CLOV currently screens at market cap $1.55B. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CLOV and COLL stock pages for the full models.
Not investment advice.